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Abstract
Background: The Hybrid Assistive Limb (HAL, CYBERDYNE) is a wearable robot that provides assistance to patients
while walking, standing, and performing leg movements based on the intended movement of the wearer.
We aimed to assess the effect of HAL training on the walking ability, range of motion (ROM), and muscle strength of
patients after total knee arthroplasty (TKA) for osteoarthritis and rheumatoid arthritis, and to compare the functional
status after HAL training to the conventional training methods after surgery.
Methods: Nine patients (10 knees) underwent HAL training (mean age 74.1 ± 5.7 years; height 150.4 ± 6.5 cm; weight
61.2 ± 8.9 kg), whereas 10 patients (11 knees) underwent conventional rehabilitation (mean age 78.4 ± 8.0 years; height
150.5 ± 10.0 cm; weight 59.1 ± 9.8 kg). Patients underwent HAL training during 10 to 12 (average 14.4 min a session)
sessions over a 4-week period, 1 week after TKA. There was no significant difference in the total physical therapy
time including HAL training between the HAL and control groups. Gait speed, step length, ROM, and muscle
strength were evaluated.
Results: The nine patients completed the HAL training sessions without adverse events. The walking speed
and step length in the self-selected walking speed condition, and the walking speed in the maximum walking speed
condition were greater in the HAL group than in the control group at 4 and 8 weeks (P < 0.05). The step length in the
maximum walking speed condition was greater in the HAL group than in the control group at 2, 4, and 8 weeks
(P < 0.05). The extension lag and knee pain were lower in the HAL group than in the control group at 2 weeks
(P < 0.05). The muscle strength of knee extension in the HAL group was greater than that in the control group at
8 weeks (P < 0.05).
Conclusion: HAL training after TKA can improve the walking ability, ROM, and muscle strength compared to
conventional physical therapy for up to 8 weeks after TKA. Since the recovery of walking ability was earlier in
the HAL group than in the control group and adverse events were not observed in this pilot study, HAL training
after TKA can be considered a safe and effective rehabilitation intervention.
Trial registration: UMIN, UMIN000017623. Registered 19 May 2015
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Background
Total knee arthroplasty (TKA) is one of the most com-
mon surgeries for severe osteoarthritis (OA) and
rheumatoid arthritis (RA) [1, 2]. Although it is possible
to eventually obtain higher physical function and quality
of life (QOL) through rehabilitation [3], physical func-
tion decreases immediately after TKA [4–6]. Moreover,
studies suggest that walking speed and walking ability
require about 1 year of recovery after TKA [6, 7]. In
addition, knee extension lag occurs early after surgery,
and restriction on range of active extension is observed
[8–10]. Therefore, gaining improved walking function ef-
ficiently is particularly important for patients after TKA.
Robot-assisted training (RAT) has been developed
since the early 2000s. There are several reports demon-
strating improvements in walking ability through the ap-
plication of RAT in patients with central nervous system
diseases, such as stroke [11], spinal cord injury [12], and
cerebral palsy [13]. However, there are few reports that
confirm the effect of RAT in postoperative rehabilitation
after TKA [14].
The Hybrid Assistive Limb (HAL, Cyberdyne Corporation,
Tsukuba, Japan) is an assisted training device. HAL is
a wearable robot that interactively provides motion
according to the wearer’s voluntary drive [15]. Details
of the HAL system have been reported in preliminary
studies [16, 17]. Both single leg and two leg versions
of the HAL are available, and the choice depends on
the wearer’s requirements. The HAL detects the bio-
electrical signals generated by the wearer’s muscle ac-
tivity or the floor-reaction-force signals caused by the
wearer’s weight shifts, or both. HAL enables lower
limb exercise and gait training with voluntary drive,
and has the advantages of both voluntary drive and
ambulatory performance. Most other exoskeleton de-
vices use autonomously generated predefined motion.
In contrast, HAL provides motion in response to the
wearer’s voluntary drive. The wearer operates HAL by
adjusting his or her own muscle activity. Clinical trials of
training using HAL have been already conducted for pa-
tients with stroke [18, 19], spinal cord injury [20], cerebral
palsy [21], and neuromuscular diseases [22], and its clin-
ical safety has been confirmed.
The study by Tanaka et al. [23] has been the only ran-
domized controlled trial that compared the lower limb
function between groups of patients who underwent
training with HAL and conventional therapy after TKA.
Although actual measured values were not described in
the article, an immediate improvement within 1 week
was observed with the use of HAL. This study was a
short-term evaluation and was conducted for up to
3 weeks after surgery, and did not examine the improve-
ment in range of motion (ROM). Moreover, the
two-legged HAL was used in this study. Furthermore,
the patients in this study had OA only, and RA was not
included. The authors suggested that the single leg HAL
may be better for functional recovery after TKA owing
to its lighter weight and because it allows freedom of
movements in the unaffected leg. Yoshioka et al. [24]
showed an improvement of postoperative extension lag
using a single joint type HAL (HAL-SJ), which is
equipped with only one actuator to the knee joint mo-
tion for TKA patients, and Fukaya et al. [25] reported an
improvement of postoperative walking ability in a case
report of a single leg version of HAL. We hypothesized
that the assistive benefit of HAL also reduces knee exten-
sion lag and improves walking ability and pre-operative
function of TKA patients not only with OA but also with
RA compared with conventional physical therapy.
Therefore, the purpose of this study was to evaluate
the effect of training using the single leg version of HAL
on walking ability, knee ROM, muscle strength, pain,
and physical function, and to compare the functional
status after HAL training with the conventional therapy
alone and with the pre-operative functional status for up
to 8 weeks after TKA for OA and RA.
Methods
Subjects
All subjects were admitted to our hospital between
February 2015 and January 2018. Patients diagnosed
with severe OA and RA via varus deformation of the
knee by X-ray examination and who underwent primary
TKA by a senior surgeon (H.M.) were included in the
study. During this period, a total of 21 consecutive pa-
tients (23 knees) underwent primary TKA. The patients
were categorized into two groups before undergoing sur-
gery (HAL and control groups). The patients who agreed
to receive HAL training and their physique allowed for
HAL device were in the HAL group, because the size of
a single leg HAL was in size medium only at that time.
The other patients were in the control group. The pa-
tients in the HAL group underwent HAL training (aver-
age 14.4 ± 5.9 min a session) and conventional physical
therapy (60 to 80 min a day) during the HAL interven-
tion period. The HAL training started 1 to 5 weeks after
TKA (HAL intervention period). The total number of
HAL interventions ranged from 10 to 12 during the
4-week period. The patients in the control group under-
went only conventional physical therapy (60 to 120 min
a day) after TKA during the HAL intervention period of
the HAL group. There was no significant difference in
the total physical therapy time including HAL training
between both groups during the HAL intervention
period. 5 weeks after TKA, the patients in the both
groups underwent same physical therapy. The physical
therapy details in the both groups are summarized in
Table 1. Eleven patients (12 knees) were included in the
Yoshikawa et al. Journal of Orthopaedic Surgery and Research  (2018) 13:163 Page 2 of 10
HAL group, whereas 10 patients (11 knees) were in the
control group. Among the 11 patients allocated to the
HAL group, 2 patients withdrew consent. One of the
two patients could not continue the study because of
worsening of depression (6 times HAL sessions were
done). Another patient withdrew, because it was
troublesome to continue the study (6 times HAL
sessions were done). Therefore, 9 patients (10 knees)
underwent HAL training. Before this study, 4 and 2
patients in the HAL and control groups, respectively,
had already undergone TKA on the contralateral
side. The pre-operative characteristics and baseline
values did not differ significantly between the two
groups (Table 2).
The ethics committee of Ibaraki Prefectural University
of Health Sciences approved the study (no. e155).
We explained the purpose of the study to the pa-
tients in verbal and written forms, and written con-
sent was obtained from all patients. The protocol of
this study was registered in the University Hospital
Medical Information Network Clinical Trials Registry
(UMIN000017623).
Surgical procedure
The surgical procedure was similar to that described in
our previous report [26]. Under general anesthesia, a
midline skin incision was made, and a medial parapatel-
lar approach was used. The patella was not replaced,
and the posterior cruciate ligament was retained. The
implants used were the NexGen® or Persona® (Zimmer,
Warsaw, IN, USA) for the femoral component and the
NexGen CR Stem Tibia or NexGen Trabecular Metal
Monoblock Tibia (Zimmer, Warsaw, IN, USA) for the
tibial component.
HAL training
The single leg version of the HAL (size medium)
(Table 1) was placed on the operative side, and the
Cybernic Voluntary Control (CVC) mode was used. The
gain in assistive torque at each joint in response to the
bioelectrical signals was controlled by a therapist so that
the patient could move the knee joint sufficiently and
easily within the ROM without aggravating pain or pres-
ence of pain and extension lag, and the walk pattern was
as normal and symmetrical as possible. First, repetitive
Table 1 Details of physical therapy and HAL training protocol
HAL group Control group P value
HAL training Single leg version HAL (size M) None
1 week to 5 weeks after TKA (4 weeks)
Number of sessions: 11.6 ± 0.8
Average duration of session: 14.4 ± 5.9 min
●Knee ROM exercises (less than 20 min)
●Gait training (less than 20 min)
Conventional PT 1 day after TKA to hospital discharge
5 or more days a week
60 to 80 min a day (during the HAL intervention period) 60 to 120 min a day (during
the HAL intervention period)
●CPM: from 3 days after TKA
●FWB: from 1 week after TKA




●Balancing training (sitting and standing positions)
●ADL training (toilet, bathing, bedside tasks, etc.)
●Bicycle ergometer training
●Various physical exercises for returning to work
●Self-exercise education
Total PT time including HAL training
during HAL intervention period
26.5 ± 4.2 (h) 28.2 ± 5.2 (h) 0.434
Values are expressed as numbers or as mean ± SD
Abbreviation: TKA, total knee arthroplasty; ROM, range of motion; PT, physical therapy; CPM, continuous passive movement; FWB, full weight-bearing; ADL, activities
of daily living
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knee flexion/extension exercises within the range where
pain was not aggravated or was absent were performed
for less than 20 min with the patient in the sitting pos-
ition. Second, gait training with HAL was conducted on
a level ground at a speed that the subject was comfort-
able with while still maintaining good gait posture, as
judged by a physical therapist, for less than 20 min. To
prevent falls, a wheeled walker was used during gait
training with HAL (Fig. 1).
Outcome measures
Indicators related to walking ability were as follows:
self-selected walking speed (SWS) [27]; maximum walk-
ing speed (MWS) [27]; mean step length at SWS
(SL-SWS) and MWS (SL-MWS); and cadence at SWS
and MWS. SWS and MWS were measured according to
the time taken to cover the intermediate 10 m of a total
distance. Measurement was performed as many times as
possible, up to a maximum of three times, and the fast-
est time was used. To calculate SL and cadence, the
number of steps in the 10-m measurement section of
the MWS or SWS test was counted. These were evalu-
ated before the surgery and at weeks 2, 4, and 8.
The assessments related to knee function were as fol-
lows: ROM of knee flexion and extension motion on
passive and active movements on the operated side;
torque of knee extension and knee flexion as muscle
strength of quadriceps and hamstrings; and Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) [28]. WOMAC validated for the Japanese
patients who had TKA surgery was divided into sub-
scales of pain (WOMAC-p) and physical function
(WOMAC-f) [29]. ROM was measured by using a med-
ical goniometer in 5 ° increments with the patients in
the sitting position or the supine position. Torques of
knee were measured with an isometric mode using Biodex
System 4 (Biodex Medical Systems, NY, USA). The knee
joint was fixed in 60 ° of knee flexion, and the maximum
knee joint flexion and extension torque were measured.
Both torques were measured in 3 sets every 5 s, and peak
torque values were used. The value obtained by dividing
the peak torque value by each body weight was used for
analysis. ROM, both torques, and both WOMAC subscale
scores were measured before the surgery and at weeks 2,
4, and 8. Four kinds of ROM were measured before the
surgery and at weeks 1, 2, 3, 4, and 8.
Statistical analysis
Differences in pre-operative subject characteristics were
analyzed using a Student’s t test or the Wilcoxon’s rank
Fig. 1 Hybrid Assistive Limb (HAL) training. Knee extension and flexion exercise while sitting, with HAL on the sagittal plane (a). Gait training, with
HAL on the sagittal plane (b)
Table 2 Preoperative baseline characteristics of subjects
Characteristics HAL group 9 patients (10 knees) Control group 10 patients (11 knees) P value
Age 74.1 ± 5.7 78.4 ± 8.0 0.180
Sex Male/female 1/8 2 / 8 1.000
Weight (kg) 61.2 ± 8.9 59.1 ± 9.8 0.612
Height (m) 150.4 ± 6.5 150.5 ± 10.0 0.985
BMI (kg/m2) 27.1 ± 3.9 26.3 ± 5.3 0.719
Disease OA/RA 8/2 10/1 0.587
TKA operated side right/left 6/4 5/6 0.670
Contralateral side TKA 4 2 0.350
Values are expressed as numbers or as mean ± SD
Abbreviation: BMI, body mass index; OA, osteoarthritis; RA, rheumatoid arthritis; TKA, total knee arthroplasty
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sum test, as appropriate, for continuous variables, and
Fisher’s exact test for categorical variables. For all out-
come measures, two-way mixed analysis of variance
(ANOVA) with repeated measures factor (from before
surgery to week 8) and between-subjects factor (HAL
group or control group) were performed for assessing 2
factor’s main effects and interaction between the 2 fac-
tors. If main effects of the repeated measures factor
(time effect) or interactions satisfied significant level
(P < 0.05) or significant large effect size (ηp
2 > 0.14),
Tukey’s honestly significant difference was used for
within-group comparisons of the outcomes at the
various assessment time points [30]. If main effects of
the between-subjects factor (intervention effect) or in-
teractions satisfied a significant level (P < 0.05) or sig-
nificant large effect size (ηp
2 > 0.14), Student’s t test
was used for comparison between groups at the vari-
ous assessment time points [30]. All analyses were
performed with IBM SPSS Statistics version 24.0
(International Business Machines Corporation, Chicago,
USA). Level of significance was set at P < 0.05.
Results
The 9 patients completed the HAL training sessions
without adverse events. All 9 patients (10 knees) in the
HAL group and 10 patients (11 knees) in the control
group were evaluated until week 4. At weeks 8, 4, and 5
patients were discharged from the hospital in the HAL
and control groups, respectively (Fig. 2).
The results of walking ability are summarized in
Table 3. At weeks 4 and 8, the SWS in the HAL group
were greater than in the control group (P = 0.030 and P
= 0.022, respectively). The SWS in the HAL group
exceeded the pre-operative value as early as week 4, and
only the HAL group showed significantly greater SWS at
week 8 than in the pre-operative period (P = 0.045)
(two-way ANOVA; intervention effect P = 0.121 and ηp
2
= 0.223; time effect P < 0.001 and ηp
2 = 0.544; and inter-
actions P = 0.304 and ηp
2 = 0.112).
At weeks 4 and 8, the MWS in the HAL group was
greater than that in the control group (P = 0.006 and
P = 0.027, respectively) (two-way ANOVA; intervention
effect P = 0.021 and ηp
2 = 0.430; time effect P = 0.001 and
ηp
2 = 0.532; and interactions P = 0.111 and ηp
2 = 0.198).
The SL at SWS in the HAL group was greater than
that in the control group at weeks 4 (P = 0.002) and 8
(P = 0.011). In the within-group comparison, only the
HAL group was found to have significantly greater SL at
SWS at weeks 4 and 8 than those at week 2 (P = 0.026 and
P = 0.003, respectively) (two-way ANOVA; intervention ef-
fect P = 0.048 and ηp
2 = 0.337; time effect P = 0.017 and
ηp
2 = 0.341; and interactions P = 0.271, ηp
2 = 0.123).
The SL at MWS in the HAL group was also greater
than that in the control groups at weeks 2 (P =
0.016), 4 (P = 0.001), and 8 (P = 0.003). In the
within-group comparison, only the HAL group was
found to have significantly greater SL at MWS at
week 4 than at week 2 (P = 0.010) (two-way ANOVA;
intervention effect P = 0.003 and ηp
2 = 0.594; time
Fig. 2 A flowchart of this study
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effect P < 0.001 and ηp
2 = 0.586; and interactions P = 0.063
and ηp
2 = 0.212).
The results of changes in the ROM are summarized in
Table 4. At weeks 2 and 4, the passive knee extension
ROM was significantly greater in the HAL group than in
the control group (P = 0.034 and P = 0.006, respectively)
(two-way ANOVA; intervention effect P = 0.135 and ηp
2
= 0.209; time effect P = 0.071 and ηp
2 = 0.238; and interac-
tions P = 0.419 and ηp
2 = 0.082). At weeks 2 and 3, the ac-
tive knee extension ROM was significantly greater in the
HAL group than in the control group (P = 0.005 and P =
0.048, respectively) (two-way ANOVA; intervention effect
P = 0.120 and ηp
2 = 0.225; time effect P = 0.082 and ηp
2 =
0.204; and interactions P = 0.262 and ηp
2 = 0.124).
The results of muscle strength are summarized in
Table 5. The knee extension torque was significantly
higher in the HAL group than in the control group at
week 8 (P = 0.014) (two-way ANOVA; intervention ef-
fect P = 0.233 and ηp
2 = 0.173; time effect P = 0.009 and
ηp
2 = 0.530; and interactions P = 0.422 and ηp
2 = 0.092).
The results of WOMAC are summarized in Table 6.
The WOMAC-P in the HAL group at week 2 was
greater than that in the control group (P = 0.021), and
the lowering of pain was recognized early in the HAL
group (two-way ANOVA; intervention effect P = 0.336
and ηp
2 = 0.103; time effect P = 0.002 and ηp
2 = 0.427;
and interactions P = 0.023 and ηp
2 = 0.293 in the
WOMAC-P, and intervention effect P = 0.073 and ηp
2 =
0.313; time effect P = 0.019 and ηp
2 = 0.304; and interac-
tions P = 0.109 and ηp
2 = 0.198 in the WOMAC-F,
respectively).
The results of two-way ANOVA in the cadence at
SWS and MWS, the passive and active knee flexion
ROM and the torque of knee flexion showed a signifi-
cant effect only in the time effect.
Discussion
The walking speed in the HAL group was better than
that in the control group at weeks 4 and 8. In addition,
the SWS of the HAL group exceeded the pre-operative
Table 3 Walking ability in the HAL and control groups
Response HAL group Control group
Visit Mean ± SD Mean ± SD P value
SWS (m/s) Pre 1.08 ± 0.29 (n = 10) 1.04 ± 0.26 (n = 11) 0.794
Week 2 0.87 ± 0.19 (n = 10) 0.77 ± 0.27 (n = 11) 0.366
Week 4 1.20 ± 0.09 (n = 10) 0.99 ± 0.26 (n = 11) 0.030 *
Week 8 1.34 ± 0.11 (n = 6) 1.05 ± 0.23 (n = 6) 0.022 *
MWS (m/s) Pre 1.41 ± 0.33 (n = 10) 1.35 ± 0.21 (n = 11) 0.588
Week 2 1.25 ± 0.38 (n = 10) 1.01 ± 0.34 (n = 11) 0.137
Week 4 1.61 ± 0.32 (n = 10) 1.24 ± 0.23 (n = 11) 0.006 **
Week 8 1.63 ± 0.09 (n = 6) 1.35 ± 0.24 (n = 6) 0.027 *
SL at SWS (m) Pre 0.59 ± 0.11 (n = 10) 0.57 ± 0.11 (n = 11) 0.656
Week 2 0.54 ± 0.05 (n = 10) 0.50 ± 0.09 (n = 11) 0.215
Week 4 0.63 ± 0.03 (n = 10) 0.53 ± 0.07 (n = 11) 0.002 **
Week 8 0.67 ± 0.03 (n = 6) 0.56 ± 0.08 (n = 6) 0.011 *
SL at MWS (m) Pre 0.67 ± 0.10 (n = 10) 0.62 ± 0.09 (n = 11) 0.274
Week 2 0.62 ± 0.06 (n = 10) 0.52 ± 0.10 (n = 11) 0.016 *
Week 4 0.70 ± 0.05 (n = 10) 0.58 ± 0.07 (n = 11) 0.001 **
Week 8 0.73 ± 0.03 (n = 6) 0.61 ± 0.07 (n = 6) 0.003 **
Cadence at SWS (m) Pre 108.1 ± 13.7 (n = 10) 109.9 ± 11.1 (n = 11)
Week 2 96.2 ± 13.7 (n = 10) 91.5 ± 22.9 (n = 11)
Week 4 115.1 ± 6.9 (n = 10) 111.3 ± 20.7 (n = 11)
Week 8 119.9 ± 5.3 (n = 6) 113.1 ± 13.4 (n = 6)
Cadence at MWS (m) Pre 125.4 ± 14.9 (n = 10) 130.7 ± 11.2 (n = 11)
Week 2 120.0 ± 25.3 (n = 10) 114.0 ± 28.4 (n = 11)
Week 4 137.7 ± 21.2 (n = 10) 127.8 ± 18.1 (n = 11)
Week 8 133.9 ± 10.0 (n = 6) 133.4 ± 20.6 (n = 6)
Abbreviations: SWS, self-selected walking speed; MWS, maximum walking speed; SL, step length
*P < 0.05; **P < 0.01
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SWS by as early as 4 weeks, and only the HAL group
showed significantly better SWS at week 8 than in the
pre-operative period. This difference exceeded the mini-
mum clinically meaningful change in walking speed sug-
gested for people with knee pain [31, 32]; thus, clinically
meaningful changes were obtained early in the HAL
group. Early recovery beyond the pre-operative period
allows early discharge and early social reversion. In
past studies, the post-operative walking speed did not
recover to the pre-operative speed at 4 or 8 weeks
Table 4 Range of motion in the HAL and control groups
Response HAL group Control group
Visit Mean ± SD Mean ± SD P value
Knee ROM (degree)
Passive extension Pre − 4.0 ± 8.4 (n = 10) − 6.4 ± 5.0 (n = 11) 0.440
Week 1 − 5.0 ± 3.3 (n = 10) − 8.6 ± 6.4 (n = 11) 0.117
Week 2 − 3.0 ± 4.2 (n = 10) − 7.7 ± 5.2 (n = 11) 0.034 *
Week 3 − 2.0 ± 3.5 (n = 10) − 5.9 ± 4.9 (n = 11) 0.051
Week 4 − 0.5 ± 1.6 (n = 10) -5.5 ± 4.7 (n = 11) 0.006 **
Week 8 − 0.8 ± 2.0 (n = 6) -4.2 ± 3.8 (n = 6) 0.086
Active extension Pre − 7.0 ± 5.4 (n = 10) − 6.8 ± 5.6 (n = 11) 0.940
Week 1 − 10.5 ± 7.6 (n = 10) − 13.2 ± 7.2 (n = 11) 0.416
Week 2 −5.0 ± 5.3 (n = 10) − 12.3 ± 5.2 (n = 11) 0.005 **
Week 3 − 4.0 ± 3.9 (n = 10) − 7.7 ± 4.1 (n = 11) 0.048 *
Week 4 − 3.5 ± 4.1 (n = 10) -6.4 ± 6.0 (n = 11) 0.220
Week 8 − 2.5 ± 2.7 (n = 6) -5.8 ± 3.8 (n = 6) 0.110
Passive flexion Pre 126.0 ± 20.2 (n = 10) 119.1 ± 18.4 (n = 11)
Week 1 95.3 ± 16.9 (n = 10) 95.5 ± 7.6 (n = 11)
Week 2 103.5 ± 11.1 (n = 10) 102.7 ± 8.8 (n = 11)
Week 3 109.5 ± 9.8 (n = 10) 108.2 ± 9.3 (n = 11)
Week 4 115.8 ± 9.2 (n = 10) 110.9 ± 10.9 (n = 11)
Week 8 122.5 ± 11.7 (n = 6) 117.8 ± 11.4 (n = 6)
Active flexion Pre 123.0 ± 22.4 (n = 10) 115.0 ± 17.0 (n = 11)
Week 1 85.5 ± 25.1 (n = 10) 85.0 ± 12.2 (n = 11)
Week 2 96.0 ± 14.3 (n = 10) 94.1 ± 10.9 (n = 11)
Week 3 100.0 ± 21.6 (n = 10) 99.5 ± 13.5 (n = 11)
Week 4 108.0 ± 15.1 (n = 10) 104.1 ± 13.0 (n = 11)
Week 8 115.8 ± 13.6 (n = 6) 109.2 ± 11.6 (n = 6)
*P < 0.05; **P < 0.01
Table 5 Muscle strength in the HAL and control groups
Response HAL group Control group
Visit Mean ± SD Mean ± SD P value
Knee extension torque (Nm/kg) Pre 1.10 ± 0.64 (n = 10) 0.91 ± 0.31 (n = 11) 0.373
Week 2 0.68 ± 0.43 (n = 10) 0.67 ± 0.23 (n = 10) 0.924
Week 4 0.93 ± 0.32 (n = 10) 0.85 ± 0.23 (n = 11) 0.541
Week 8 1.15 ± 0.12 (n = 6) 0.88 ± 0.17 (n = 5) 0.014 *
Knee flex torque (Nm/kg) Pre 0.56 ± 0.22 (n = 10) 0.51 ± 0.22 (n = 11)
Week 2 0.36 ± 0.15 (n = 10) 0.41 ± 0.15 (n = 10)
Week 4 0.45 ± 0.16 (n = 10) 0.41 ± 0.15 (n = 11)
Week 8 0.51 ± 0.12 (n = 6) 0.50 ± 0.15 (n = 5)
*P < 0.05
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postoperatively [33, 34], but was found to recover by
12 weeks [4, 5, 7, 31]. Owing to the early recovery in
walking speed, it can be stated that HAL training can
be an effective rehabilitation intervention for patients
after TKA.
At weeks 2 and 3, the active knee extension ROM in
the HAL group was better than that in the control
group. Extension lag has been reported to be associated
with muscle strain reduction in the quadriceps muscles
[9]. Improvement in extension lag at week 2 implies
recovery of knee extension, possibly through a potential
neuromuscular mechanism [8, 35], and might have led
to an improvement in the knee extension torque in the
HAL group than in the control group, which was ob-
served at weeks 8. In a case report where a HAL-SJ was
applied after TKA [26], the authors suggested that im-
provement in the extension lag was brought about by
the HAL-SJ-mediated promotion of muscle and nerve
function in the quadriceps muscle. Due to the assistance
during knee motion, the extension lag during walking
decreased, and it was believed that the increase in step
length led to an improvement in walking speed. Simi-
larly, in our previous study on HAL training in stroke
patients, improvements in walking speed accompanied
by improvements in gait symmetry and increase in step
length were observed [36]. The torque assistance pro-
vided by the HAL allows the therapist to gradually ad-
just the magnitude of the myoelectric potential emitted
by the patient in real time, and it allows the adjustment
of the degree of effort required by the patient to walk
almost normally. The involvement of repetitive move-
ments and voluntary activities is an important factor
for motor learning [37, 38]. HAL training for
post-TKA patients seems to be a voluntary iterative
exercise of sensory feedback of normal joint move-
ment and walking pattern.
The WOMAC-P score was significantly greater in
the HAL group than in the control group, indicating
that postoperative pain was relieved by early as week 2.
Knee pain is associated with abnormal muscle activity
[39], co-contraction [40], and weakness [41], and it is
known to affect extension lag [10] and walking ability
[42]. By using HAL, gradual assistance is provided to
patients so that pain is not experienced or aggravated,
and exercises are conducted so as not to cause
co-contraction of the flexion and extension muscles
at an early stage. These may have contributed to the
improvement in walking ability and the reduction in
extension lag.
In the HAL group, the patients could participate in all
sessions without experiencing adverse events. HAL
training after TKA can therefore be considered safe. In
fact, the time of HAL training is unexpectedly less than
the set time limit, and it seems that the cost effective-
ness and wearing time of HAL training should be evalu-
ated in future trials.
Limitations
Although there is no difference between the two
groups in terms of patients’ background, this study
was non-randomized and non-blinded with a small
number of patients. Since the size of single leg HAL
was medium only at that time, only the patients who
agreed to receive HAL training and their physique
allowed for HAL device underwent HAL training.
Moreover, there is no data over 8 weeks. Therefore,
in the future, a randomized controlled trial with a
larger number of patients and longer follow-up is ne-
cessary to consider as potential bias risks. However,
the intervention procedure and evaluation items in
this study are reasonable, and this pilot study can be
helpful in planning the future randomized controlled
trial. Although there is no significant difference be-
tween the two groups in the number of cases that
already undergone TKA on the contralateral side and
the total physical therapy time including HAL train-
ing, it is necessary to align these precisely in the
future study.
Table 6 Knee pain and functionality in the HAL and control groups
Response HAL group Control group
Visit Mean ± SD Mean ± SD P value
WOMAC-P Pre 72.0 ± 13.4 (n = 10) 60.0 ± 23.2 (n = 11) 0.169
Week 2 78.0 ± 15.7 (n = 10) 59.1 ± 18.4 (n = 11) 0.021 *
Week 4 79.0 ± 12.4 (n = 10) 80.0 ± 13.6 (n = 11) 0.863
Week 8 88.0 ± 5.7 (n = 5) 79.2 ± 14.6 (n = 6) 0.218
WOMAC-F Pre 82.2 ± 16.9 (n = 10) 74.6 ± 15.0 (n = 11) 0.287
Week 2 82.8 ± 14.5 (n = 9) 69.6 ± 19.0 (n = 10) 0.110
Week 4 86.5 ± 10.6 (n = 10) 83.3 ± 11.3 (n = 11) 0.515
Week 8 92.6 ± 6.6 (n = 5) 85.3 ± 5.7 (n = 6) 0.077
Abbreviations: Western Ontario and McMaster Universities Osteoarthritis Index WOMAC-P, Subscale of pain in WOMAC; WOMAC-F, Subscale of function in WOMAC
*P < 0.05
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Conclusion
HAL training after TKA can improve walking speed,
step length, early active knee extension ROM, and
muscle strength without severe pain better than conven-
tional rehabilitation for up to 8 weeks after TKA. Since
the recovery of walking ability was earlier in the HAL
group than in the control group and no adverse
events were noted, HAL training can be considered a
safe and effective rehabilitation intervention for pa-
tients who have undergone TKA. Since this study was
a preliminary study, a randomized controlled trial
with a larger number of patients and loner follow-up
is necessary in the future.
Abbreviations
ADL: Activities of daily living; ANOVA: Analysis of variance; CVC: Cybernic
Voluntary Control; HAL: Hybrid Assistive Limb; MWS: Maximum walking
speed; OA: Osteoarthritis; QOL: Quality of life; RA: Rheumatoid arthritis;
RAT: Robot-assisted training; ROM: Range of motion; SL-MWS: Step length at
maximum walking speed; SL-SWS: Step length at self-selected walking speed;
SWS: Self-selected walking speed; TKA: Total knee arthroplasty; WOMAC: Western
Ontario and McMaster Universities Osteoarthritis Index; WOMAC-f: Subscale of
function in WOMAC; WOMAC-p: Subscale of pain in WOMAC
Acknowledgements
We are grateful to the physical therapists at Ibaraki Prefectural University of
Health Sciences Hospital who helped in the intervention and assessment.
Funding
This work was supported by Grant-in-Aid for Project Research (1655) from
Ibaraki Prefectural University of Health Sciences.
Availability of data and materials
The datasets generated and/or analyzed during the current study are available
from the corresponding author by reasonable request.
Authors’ contributions
KY participated in the design of the study, performed the data collection,
analysis, and interpretation, and drafted and revised the manuscript. HM
participated in the design of the study and analysis, collected patient’s informed
consent, performed TKAs, and drafted and revised the manuscript. AS and KK
performed the HAL training and assessments. TF performed the assessments. MM
and MY participated in the coordination and design of the study and in finalizing
the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The ethics committee of Ibaraki Prefectural University of Health Sciences
approved the study (nos. 637 and e146). Informed consent was obtained
from the patients.
Consent for publication
Written informed consent for the publication of Fig. 1 was obtained from
the patient.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Physical Therapy, Ibaraki Prefectural University of Health
Sciences Hospital, 4773 Ami, Ami-machi, Inashiki-gun, Ibaraki 300-0331,
Japan. 2Department of Orthopaedic Surgery, Ibaraki Prefectural University of
Health Sciences, 4669-2 Ami, Ami-machi, Inashiki-gun, Ibaraki 300-0394,
Japan. 3Department of Physical Therapy, Faculty of Health Sciences, Tsukuba
International University, 6-8-33 Manabe, Tsuchiura, Ibaraki 300-0051, Japan.
4Department of Physical Therapy, Ibaraki Prefectural University of Health
Sciences, 4669-2 Ami, Ami-machi, Inashiki-gun, Ibaraki 300-0394, Japan.
5Department of Orthopaedic Surgery, Faculty of Medicine, University of
Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Received: 28 May 2018 Accepted: 25 June 2018
References
1. Sanna M, Sanna C, Caputo F, Piu G, Salvi M. Surgical approaches in total
knee arthroplasty. Joints. 2013;1:34.
2. Gøthesen Ø, Espehaug B, Havelin L, Petursson G, Lygre S, Ellison P, et al.
Survival rates and causes of revision in cemented primary total knee
replacement: a report from the Norwegian arthroplasty register 1994–2009.
Bone Joint J. 2013;95:636–42.
3. Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster J-Y. Health-related
quality of life in total hip and total knee arthroplasty: a qualitative and
systematic review of the literature. JBJS. 2004;86:963–74.
4. Mizner RL, Petterson SC, Snyder-Mackler L. Quadriceps strength and the
time course of functional recovery after total knee arthroplasty. J Orthop
Sports Phys Ther. 2005;35:424–36.
5. Turcot K, Sagawa Y Jr, Fritschy D, Hoffmeyer P, Suva D, Armand S. How gait
and clinical outcomes contribute to patients’ satisfaction three months
following a total knee arthroplasty. J Arthroplast. 2013;28:1297–300.
6. Pua YH, Seah FJ, Clark RA, Lian-Li Poon C, Tan JW, Chong HC. Factors associated
with gait speed recovery after total knee arthroplasty: a longitudinal study. Semin
Arthritis Rheum. 2017;46:544–51.
7. Yoshida Y, Mizner RL, Ramsey DK, Snyder-Mackler L. Examining outcomes
from total knee arthroplasty and the relationship between quadriceps
strength and knee function over time. Clin Biomech. 2008;23:320–8.
8. Sakamoto R, Takemasa S, Nakagawa N. Extensor lag after the total knee
arthroplasty for the knee oseteoarthritis. Bulletin of Kobe University
Graduate School of Health Sciences. 2009;24:29-39.
9. Sprague RB. Factors related to extension lag at the knee joint. J Orthop Sports
Phys Ther. 1982;3:178–82.
10. Gotlin RS, Hershkowitz S, Juris PM, Gonzalez EG, Scott WN, Insall JN. Electrical
stimulation effect on extensor lag and length of hospital stay after total knee
arthroplasty. Arch Phys Med Rehabil. 1994;75:957–9.
11. Mehrholz J, Elsner B, Werner C, Kugler J, Pohl M. Electromechanical-assisted
training for walking after stroke updated evidence. Stroke. 2013;44:e127-e8.
12. Cheung EYY, Ng TKW, Yu KKK, Kwan RLC, Cheing GLY. Robot-assisted
training for people with spinal cord injury: a meta-analysis. Arch Phys
Med Rehabil. 2017;98:2320–31.
13. Carvalho I, Pinto SM, das Virgens Chagas D, dos Santos JLP, de Sousa
Oliveira T, Batista LA. Robotic gait training for individuals with cerebral
palsy: a systematic review and meta-analysis. Arch Phys Med Rehabil.
2017;98:2332–44.
14. Henderson KG, Wallis JA, Snowdon DA. Active physiotherapy interventions
following total knee arthroplasty in the hospital and inpatient rehabilitation
settings: a systematic review and meta-analysis. Physiotherapy. 2018;104:25–35.
15. Kawamoto H, Kamibayashi K, Nakata Y, Yamawaki K, Ariyasu R, Sankai Y,
et al. Pilot study of locomotion improvement using hybrid assistive limb in
chronic stroke patients. BMC Neurol. 2013;13:141.
16. Kawamoto H, Taal S, Niniss H, Hayashi T, Kamibayashi K, Eguchi K, et al.,
editors. Voluntary motion support control of robot suit HAL triggered by
bioelectrical signal for hemiplegia. Conf Proc IEEE Eng Med Biol Soc. 2010;
2010:462-6.
17. Suzuki K, Mito G, Kawamoto H, Hasegawa Y, Sankai Y. Intention-based
walking support for paraplegia patients with robot suit HAL. Adv Robot.
2007;21:1441–69.
18. Nilsson A, Vreede KS, Haglund V, Kawamoto H, Sankai Y, Borg J. Gait training
early after stroke with a new exoskeleton–the hybrid assistive limb: a study
of safety and feasibility. J Neuroeng Rehabil. 2014;11:92.
19. Watanabe H, Tanaka N, Inuta T, Saitou H, Yanagi H. Locomotion improvement
using a hybrid assistive limb in recovery phase stroke patients: a randomized
controlled pilot study. Arch Phys Med Rehabil. 2014;95:2006–12.
20. Sczesny-Kaiser M, Höffken O, Aach M, Cruciger O, Grasmücke D, Meindl R,
et al. HAL® exoskeleton training improves walking parameters and normalizes
cortical excitability in primary somatosensory cortex in spinal cord injury
patients. J Neuroeng Rehabil. 2015;12:1.
Yoshikawa et al. Journal of Orthopaedic Surgery and Research  (2018) 13:163 Page 9 of 10
21. Matsuda M, Mataki Y, Mutsuzaki H, Yoshikawa K, Takahashi K, Enomoto K, et al.
Immediate effects of a single session of robot-assisted gait training using
Hybrid Assistive Limb (HAL) for cerebral palsy. J Phys Ther Sci. 2018;30:207–12.
22. Sugimura Y, Takahashi T, Iijima Y, Nakajima H, Fujiya Y, Shimosegawa Y,
et al. The efficacy of treatment using hybrid assistive limb for patients
with neuromuscular disease. J Neurol Sci. 2017;381:836.
23. Tanaka Y, Oka H, Nakayama S, Ueno T, Matsudaira K, Miura T, et al. Improvement
of walking ability during postoperative rehabilitation with the hybrid assistive
limb after total knee arthroplasty: a randomized controlled study. SAGE Open
Med. 2017;5:2050312117712888.
24. Yoshioka T, Sugaya H, Kubota S, Onishi M, Kanamori A, Sankai Y, et al. Knee-
extension training with a single-joint hybrid assistive limb during the early
postoperative period after total knee arthroplasty in a patient with
osteoarthritis. Case Rep Orthop. 2016;2016:9610745.
25. Fukaya T, Mutsuzaki H, Yoshikawa K, Sano A, Mizukami M, Yamazaki M. The
training effect of early intervention with a hybrid assistive limb after total
knee arthroplasty. Case Rep Orthop. 2017;2017:1.
26. Mutsuzaki H, Takeuchi R, Mataki Y, Wadano Y. Target range of motion for
rehabilitation after total knee arthroplasty. J Rural Med. 2017;12:33–7.
27. Bohannon RW. Comfortable and maximum walking speed of adults aged
20—79 years: reference values and determinants. Age Ageing. 1997;26:15–9.
28. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation
study of WOMAC: a health status instrument for measuring clinically important
patient relevant outcomes to antirheumatic drug therapy in patients with
osteoarthritis of the hip or knee. Rheumatol. 1988;15:1833–40.
29. Hashimoto H, Hanyu T, Sledge CB, Lingard EA. Validation of a Japanese
patient-derived outcome scale for assessingtotal knee arthroplasty: comparison
with Western Ontario and McMaster Universities osteoarthritis index (WOMAC).
J Orthop Sci. 2003;8:288–93.
30. Huck SW. Reading statistics and research sixth edition. 6th ed. Boston: Pearson; 2012.
31. Abbasi-Bafghi H, Fallah-Yakhdani HR, Meijer OG, de Vet HC, Bruijn SM, Yang
L-Y, et al. The effects of knee arthroplasty on walking speed: a meta-analysis.
BMC Musculoskelet Disord. 2012;13:66.
32. White DK, Felson DT, Niu J, Nevitt MC, Lewis CE, Torner JC, et al. Reasons for
functional decline despite reductions in knee pain: the multicenter osteoarthritis
study. Phys Ther. 2011;91:1849–56.
33. Fusi S, Campailla E, Causero A, di Prampero P. The locomotory index: a new
proposal for evaluating walking impairments. Int J Sports Med. 2002;23:105–11.
34. Parent E, Moffet H. Comparative responsiveness of locomotor tests and
questionnaires used to follow early recovery after total knee arthroplasty.
Arch Phys Med Rehabil. 2002;83:70–80.
35. Kennedy JC, Alexander IJ, Hayes KC. Nerve supply of the human knee and
its functional importance. Am J Sports Med. 1982;10:329–35.
36. Yoshikawa K, Mizukami M, Kawamoto H, Sano A, Koseki K, Sano K, et al. Gait
training with Hybrid Assistive Limb enhances the gait functions in subacute
stroke patients: a pilot study. NeuroRehabilitation. 2017;40:87–97.
37. Pennycott A, Wyss D, Vallery H, Klamroth-Marganska V, Riener R. Towards
more effective robotic gait training for stroke rehabilitation: a review.
J Neuroeng Rehabil. 2012;9:65.
38. Lotze M, Braun C, Birbaumer N, Anders S, Cohen LG. Motor learning elicited
by voluntary drive. Brain. 2003;126:866–72.
39. Rice DA, McNair PJ. Quadriceps arthrogenic muscle inhibition: neural
mechanisms and treatment perspectives. Semin Arthritis Rheum. 2010;40:250–66.
40. Preece SJ, Jones RK, Brown CA, Cacciatore TW, Jones AK. Reductions in co-
contraction following neuromuscular re-education in people with knee
osteoarthritis. BMC Musculoskelet Disord. 2016;17:372.
41. Perry J, Davids JR. Gait analysis: normal and pathological function. NJ: Slack;
1992. p. 815.
42. Lee I-h, S-y P. A comparison of gait characteristics in the elderly people,
people with knee pain, and people who are walker dependent people.
J Phys Ther Sci. 2013;25:973–6.
Yoshikawa et al. Journal of Orthopaedic Surgery and Research  (2018) 13:163 Page 10 of 10
